Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATRA | AZN | AMGN | GILD | VRTX |
| Company | Atara Biotherap | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 15.10 | 95.18 | 337.76 | 124.08 | 481.51 |
| High | 17.97 | 95.95 | 341.46 | 125.11 | 485.69 |
| Low | 14.90 | 94.88 | 334.40 | 121.35 | 478.79 |
| Latest | 17.05 | 94.82 | 334.10 | 121.55 | 480.35 |
| Change | +2.11 | -0.34 | -7.54 | -2.80 | -3.80 |
| % Change | +14.12% | -0.36% | -2.21% | -2.25% | -0.78% |
| Volume | 286,089 | 2,640,633 | 791,168 | 2,723,779 | 541,150 |
| 20-Day Average Volume | 111,082 | 4,652,556 | 2,721,879 | 6,230,421 | 1,241,564 |
| Previous Close | 14.94 | 95.16 | 341.64 | 124.35 | 484.15 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 17.27 | 92.02 | 327.55 | 122.41 | 457.70 |
| 20-Day Raw Stochastic | 61.95% | 79.67% | 74.07% | 43.87% | 89.55% |
| 20-Day Relative Strength | 55.34 | 64.45 | 55.59 | 48.64 | 65.85 |
| Weighted Alpha | +116.67 | +45.83 | +27.98 | +29.57 | +20.21 |
| Today's Opinion | 96% Buy | 100% Buy | 96% Buy | 40% Buy | 88% Buy |
| Previous Opinion | 64% Buy | 100% Buy | 96% Buy | 72% Buy | 88% Buy |
| Last Month's Opinion | 72% Buy | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.42% since 12/31/25 | +3.38% since 12/31/25 | +2.38% since 12/31/25 | -1.01% since 12/31/25 | +6.30% since 12/31/25 |
| Low | 14.27 on 01/06/26 | 89.53 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 443.12 on 01/05/26 |
| High | 19.15 on 01/05/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 125.11 on 01/08/26 | 487.52 on 01/07/26 |
| 1-Month | |||||
| %Chg | +14.66% since 12/08/25 | +4.12% since 12/08/25 | +4.32% since 12/08/25 | +0.26% since 12/08/25 | +9.02% since 12/08/25 |
| Low | 14.27 on 01/06/26 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 433.81 on 12/10/25 |
| High | 19.15 on 01/05/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +9.09% since 10/08/25 | +11.31% since 10/08/25 | +13.74% since 10/08/25 | +2.75% since 10/08/25 | +14.43% since 10/08/25 |
| Low | 10.50 on 11/05/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 402.58 on 10/13/25 |
| High | 19.15 on 01/05/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +86.52% since 07/08/25 | +35.73% since 07/08/25 | +12.83% since 07/08/25 | +9.40% since 07/08/25 | +3.33% since 07/08/25 |
| Low | 8.53 on 07/17/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 19.15 on 01/05/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 107,720 | 295,134,176 | 183,966,656 | 154,278,560 | 122,838,048 |
| Shares Outstanding, K | 7,210 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 128,940,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -85,400,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 3,450,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -4,300,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | -0.41 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/12/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/06/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 6.68 | 20.78 | 15.10 | 14.82 | 30.59 |